相关实验视频
Updated: Sep 11, 2025

06:12
Technical Aspects of the Mouse Aortocaval Fistula
Published on: July 11, 2013
16.8K
延迟表现的脏动脉静脉和伪动脉瘤在原生左在合移植接受者:一个案例报告
Amey Narkhede1, Ajit Yadav1, Manish Malik1
1Department of Interventional Radiology, Sir Ganga Ram Hospital, Rajinder Nagar, Delhi, India.
JNMA; journal of the Nepal Medical Association
|August 13, 2025
概括
在脏活检后延迟的动脉静脉和伪动脉瘤是罕见的. 这一案例突出显示,在移植患者的活检后6年,这些并发症的成功栓塞.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 干预性放射学 干预性放射学
- 移植手术 移植手术
背景情况:
- 活检后的阳性并发症,如动脉静脉 (AVF) 和伪动脉瘤,通常在几天到几周内表现出来.
- 这些血管并发症在手术多年后延迟出现并不常见,这给诊断和治疗带来了挑战.
研究的目的:
- 报告一个罕见的病例延迟的动脉静脉和伪动脉瘤形成的脏活检后.
- 描述移植受体中这种晚期并发症的成功干预管理.
主要方法:
- 一名32岁的男性移植受体出现腰部疼痛6年后左活检.
- 诊断血管造影显示了动脉静脉和涉及左动脉的伪动脉瘤.
- 超选择性栓塞使用线圈,高度粘剂和临时静脉封闭气球进行.
主要成果:
- 栓塞程序取得了完全的技术和临床成功.
- 患者经历了腰部疼痛的消失,并且没有立即的术后并发症.
结论:
- 这一案例凸显出,原性血管并发症可以在初始活检多年后出现.
- 超选择性栓塞是一种有效的治疗延迟的动脉静脉和瘤在脏活检后.
相关概念视频
Kidney Transplant II: Surgical Procedure
75
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75
Hemodialysis I: Introduction
290
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
290
Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60

